Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 90
Summary
- Conditions
- Congestive Heart Failure
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 13 years and 125 years
- Gender
- Both males and females
Description
Brief description of procedures: After informed consent is obtained from the patient, the blood samples will be obtained either during a procedure from access lines inserted for the procedure or they will be drawn when other ordered lab work is done at specific time points during the study. Tissue s...
Brief description of procedures: After informed consent is obtained from the patient, the blood samples will be obtained either during a procedure from access lines inserted for the procedure or they will be drawn when other ordered lab work is done at specific time points during the study. Tissue samples will be obtained at the time of LVAD implantation by keeping the part of the left ventricular apex that the surgeon is removing in order to place the inflow cannula of the LVAD. No extra tissue sample, other than the tissue that has to be removed as a part of a standard LVAD, will be collected.
Tracking Information
- NCT #
- NCT01099982
- Collaborators
- Intermountain Health Care, Inc.
- VA Salt Lake City Health Care System
- Hunter Holmes McGuire VA Medical Center
- Investigators
- Study Director: Dean Y Li, M.D., Ph.D. University of Utah Principal Investigator: Josef Stehlik, M.D., M.P.H. University of Utah Health Sciences Center & VA Salt Lake City Health Care System Study Director: Stavros G Drakos, M.D., Ph.D. University of Utah
Get Well Soon